PTIX
USDProtagenic Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.220
High
$2.290
Low
$2.140
Volume
0.03M
Company Fundamentals
Market Cap
4.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.71M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Delay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company developing novel neuro-active
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company
Related Stocks
LUNRW
Intuitive Machines Inc. Warrants
TBB
AT&T Inc. 5.350% Global Notes due 2066
SCCC
Sachem Capital Corp. 7.75% Notes due 2025
GRNT
Granite Ridge Resources Inc.
BYM
Blackrock Municipal Income Quality Trust Common Shares of Beneficial Interest
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.